The BalancedInvestor Club

BDSX Market Analysis

Overview

Fundamentals

P/E ratio—
EPS (TTM)$-4.670.0% YoY
Profit margin-39.9%HEALTHCARE
Market cap$112.0MMicro cap

Wall Street coverage

$30.00median target· current $30.40 (-1.3%)5 analysts

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

Valuation

Forward P/E
—
PEG ratio
—
P/B
44.57
P/S (TTM)
1.26
EV/EBITDA
-2.72

Profitability & growth

ROE (TTM)
-383.1%
Operating margin
-6.8%
Revenue growth YoY
40.8%
Dividend yield
—
Beta
0.57
Last earnings
Feb 27, 2026 · Estimate $-0.87 · Reported $-0.49
Analyst estimate. Actual results often differ.

Ratios are point-in-time. Historical metrics — no guarantees about what comes next.

News & Sentiment

Page 1 of 3 · 50 total

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

About Biodesix Inc

Biodesix, Inc. operates a data-driven diagnostic solutions company in the United States. The company is headquartered in Boulder, Colorado.

Classification

Sector
Healthcare
Industry
Diagnostics & Research
Exchange
NASDAQ
Country
USA
Currency
USD

Company profile

HQ
919 WEST DILLON ROAD, LOUISVILLE, CO
Fiscal year end
December
Latest quarter
Dec 31, 2025
Market cap$112.0M
Shares outstanding$10.1M
52W high$20.21
52W low$3.44

Educational content · Not investment advice or recommendations

We're educators, not advisors. Your decisions are your own. Disclaimer